Soligenix (NASDAQ: SNGX) is a late-stage biopharmaceutical company focused on developing and commercializing treatments for rare diseases with high unmet medical needs. “Operati ...

A key trend that has shaped the market is the rise of algorithmic trading. In FY15, algorithmic trades accounted for 37% of the cash market turnover, but this figure has now surged to 53% in FY25, ...